THC
20–23%
CBD
1%
HoneyFace is a hybrid from breeder Twenty20 that tests 20-23% THC alongside up to 1% CBD, a strong potency combination.
No effect, terpene, flavor or medical-use data specific to HoneyFace has been published yet, so we don't guess. For what hybrid strains usually do, see the effects guide.
THC in this profile
23% THC
About HoneyFace
HoneyFace, offered by breeder Twenty20, sits in a strong potency bracket, with THC testing from 20 up to 23 percent, comfortably above where most everyday hybrids land. A modest CBD ceiling of up to 1 percent rounds out the cannabinoid profile, adding a small secondary compound alongside the primary THC punch. Beyond those two numbers, though, the public record is thin: no effects, flavors, terpenes, or medical applications have been documented for this cut. That leaves shoppers judging HoneyFace almost entirely on raw potency rather than a fuller sensory description, which is a fine basis for a decision if strength is the priority but leaves plenty of open questions about aroma or how it actually feels. Until more testing gets published, the 20-to-23-percent THC range paired with that small CBD presence is the whole story this listing has to tell.
Where to Buy Seeds
We may earn a commission from purchases made through these links.
Frequently Asked Questions about HoneyFace
Is HoneyFace an Indica, Sativa, or Hybrid?
HoneyFace is classified as a hybrid cannabis strain.
What cannabinoid content is reported for HoneyFace?
HoneyFace: 23% THC and 1% CBD reported in our data. The THC figure, when present, is the upper end of the reported range, not a typical measured dose. Potency can vary across harvests, phenotypes, and growing conditions.